Skip to main content

Table 1 Patient characteristics

From: A low initial serum sodium level is associated with an increased risk of overcorrection in patients with chronic profound hyponatremia: a retrospective cohort analysis

Parameters

Missing

Total

(n = 56)

No-Overcorrection

(n = 45)

Overcorrection

(n = 11)

p-value

Age, years old

0

78 (60–83)

79 (63–84)

60 (48–82)

0.129

Male

0

27 (48.2)

22 (48.9)

5 (45.5)

0.838

Body weight, kg

0

52 (42–60)

50 (40–58)

56 (51–69)

0.049

Symptoms

 Severe symptoms

  Seizures

0

3 (5.4)

0 (0.0)

3 (27.3)

<0.001

  Coma

0

0 (0.0)

0 (0.0)

0 (0.0)

  Cardiorespiratory distress

0

0 (0.0)

0 (0.0)

0 (0.0)

 Other symptoms

  Vomit

0

13 (23.2)

9 (20.0)

4 (36.4)

0.249

  Nausea

0

9 (16.1)

7 (15.6)

2 (18.2)

0.832

  Loss of appetite

0

10 (17.9)

10 (22.2)

0 (0.0)

0.085

  Disorientation

0

34 (60.7)

28 (62.2)

6 (54.5)

0.640

  Impairment of gait or fall

0

10 (17.9)

9 (20.0)

1 (9.1)

0.397

  General fatigue

0

3 (5.4)

3 (6.7)

0 (0.0)

0.379

 Asymptomatic

0

3 (5.4)

2 (4.4)

1 (9.1)

0.540

Cause of hyponatremia

 Primary polydipsia

0

6 (10.7)

2 (4.4)

4 (36.4)

0.002

 Poor solute intake

0

21 (37.5)

17 (37.8)

4 (36.4)

0.931

 Hypovolemic hyponatremia

0

36 (64.3)

30 (66.7)

6 (54.5)

0.452

 SIADH

0

4 (7.1)

4 (8.9)

0 (0.0)

0.305

 Physiological stimulation of ADH

0

11 (19.6)

9 (20.0)

2 (18.2)

0.892

 CSW

0

2 (3.6)

2 (4.4)

0 (0.0)

0.476

 Drug intoxication

0

10 (17.9)

8 (17.8)

2 (18.2)

0.975

 Unidentified

0

1 (1.8)

1 (2.2)

0 (0.0)

0.618

Underlying disease

 Psychiatric disease

0

6 (10.7)

3 (6.7)

3 (27.3)

0.048

  Schizophrenia

0

1 (1.8)

0 (0.0)

1 (9.1)

0.041

  Anorexia nervosa

0

1 (1.8)

1 (2.2)

0 (0.0)

0.618

  Depression

0

3 (5.4)

2 (4.4)

1 (9.1)

0.540

  Development disorder

0

1 (1.8)

0 (0.0)

1 (9.1)

0.041

 Infectious disease

0

14 (25.0)

13 (28.9)

1 (9.1)

0.174

  Urinary tract infection

0

5 (8.9)

4 (8.9)

1(9.1)

0.983

  Pneumonia

0

3 (5.4)

3 (6.7)

0 (0.0)

0.379

  Thoracic empyema

0

1 (1.8)

1 (2.2)

0 (0.0)

0.618

  Meningitis

0

2 (3.6)

2 (4.4)

0 (0.0)

0.476

  Influenza

0

2 (3.6)

2 (4.4)

0 (0.0)

0.476

  Cellulitis

0

2 (3.6)

2 (4.4)

0 (0.0)

0.476

  HIV

0

1 (1.8)

1 (2.2)

0 (0.0)

0.618

 Malignant disease

0

6 (10.7)

5 (11.1)

1 (9.1)

0.846

  Stomach

0

1 (1.8)

1 (2.2)

0 (0.0)

0.618

  Pancreatic

0

2 (3.6)

2 (4.4)

0 (0.0)

0.476

  Renal

0

1 (1.8)

1 (2.2)

0 (0.0)

0.618

  Prostatic

 

2 (3.6)

1 (2.2)

1 (9.1)

0.271

 Alcohol abuse

0

4 (7.1)

3 (6.7)

1 (9.1)

0.780

 Unidentified

0

28 (50.0)

23 (51.1)

5 (45.5)

0.737

Medication on admission

 Thiazide

0

7 (12.5)

5 (11.1)

2 (18.2)

0.525

 Antipsychotic drug

0

2 (3.6)

2 (4.4)

0 (0.0)

0.476

 DDAVP

0

2 (3.6)

2 (4.4)

0 (0.0)

0.476

  1. ADH antidiuretic hormone, CSW cerebral salt wasting, DDAVP desmopressin, HIV human immunodeficiency virus, and SIADH syndrome of inappropriate antidiuretic hormone
  2. Categorical variables are shown as numbers (percentages) and continuous variables as medians (25–75 percentiles)